Federal legislative reform is an historic opportunity not only to strengthen the US FDA’s oversight of the cosmetics sector, but also to modernize the industry and its value proposition to consumers. John Bailey, independent advisor for cosmetics and colors at EAS Consulting Group, is confident there’s a way to do all, but "serious" stakeholder negotiations are needed.
Industry veteran John Bailey, who served a decade as director of the US Food and Drug Administration’s Office of Cosmetics and Colors, is confident there is a way to meaningfully update federal cosmetics regulations to benefit all stakeholders.
The Senate’s current proposal in the FDA Safety and Landmark Advancements (FDASLA) Act,